
- Amneal Pharmaceuticals (AMRX) is trading at new 5-year highs with strong technical momentum.
- AMRX has gained 69% over the past year.
- Shares maintain a 100% “Buy” technical opinion on Barchart.
- Analyst sentiment is positive, with multiple “Strong Buy” ratings and price targets as high as $15.